GROUP ONE TRADING, L.P. - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is and the CUSIP is H17182908. A total of 5 filers reported holding CRISPR THERAPEUTICS AG in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q3 2023$2,727,939
-36.7%
60,100
-21.7%
0.01%
-35.7%
Q2 2023$4,311,552
+56.8%
76,800
+26.3%
0.01%
+40.0%
Q1 2023$2,749,984
-66.1%
60,800
-69.6%
0.01%
-47.4%
Q4 2022$8,117,805
-42.4%
199,700
-7.5%
0.02%
-32.1%
Q3 2022$14,103,000
+11.2%
215,800
+3.4%
0.03%
+40.0%
Q2 2022$12,683,000
-26.5%
208,700
-24.1%
0.02%
+17.6%
Q1 2022$17,255,000
-72.4%
274,900
-66.7%
0.02%
-66.0%
Q4 2021$62,572,000
-40.5%
825,700
-12.2%
0.05%
-56.1%
Q3 2021$105,203,000
-8.7%
939,900
+32.0%
0.11%
-18.0%
Q2 2021$115,266,000
+21.1%
712,000
-8.9%
0.14%
-1.4%
Q1 2021$95,201,000
+39.9%
781,300
+75.8%
0.14%
+19.5%
Q4 2020$68,027,000
+1360.1%
444,300
+697.7%
0.12%
+686.7%
Q3 2020$4,659,000
+5.0%
55,700
-7.8%
0.02%
-25.0%
Q2 2020$4,439,000
+89.9%
60,400
+9.6%
0.02%
+5.3%
Q1 2020$2,337,000
-87.1%
55,100
-81.5%
0.02%
-84.7%
Q4 2019$18,168,000
+723.9%
298,300
+454.5%
0.12%
+588.9%
Q3 2019$2,205,000
+24.9%
53,800
+43.5%
0.02%
+12.5%
Q2 2019$1,766,000
+23.9%
37,500
-6.0%
0.02%0.0%
Q1 2019$1,425,000
-10.0%
39,900
-28.0%
0.02%
+14.3%
Q4 2018$1,583,000
-22.4%
55,400
+20.4%
0.01%
-12.5%
Q3 2018$2,040,000
+57.0%
46,000
+108.1%
0.02%
+45.5%
Q2 2018$1,299,000
+15.6%
22,100
-10.2%
0.01%0.0%
Q1 2018$1,124,000
+22380.0%
24,600
+12200.0%
0.01%
Q4 2017$5,0002000.00%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q2 2022
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 60,100$2,727,9390.01%
IMC-Chicago, LLC 157,400$7,144,3860.01%
SIMPLEX TRADING, LLC 83,200$3,7760.00%
JANE STREET GROUP, LLC 174,900$7,938,7110.00%
OSAIC HOLDINGS, INC. 1$1,2400.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of CRISPR THERAPEUTICS AG shareholders